THRX
{"sector":"Healthcare","industry":"Drugs","symbol":"THRX","company_name":"Theravance, Inc.","exchange":"NASDAQ"}THRX Articles
Jon OggWe are in the thick of corporate earnings season and stocks are challenging all-time highs. This is a climate in which investors want and need to know which stocks to buy and which to sell....
Published:
thinkstockHere are today’s five biggest gaining stocks at closing: Overstock.com (NASDAQ: OSTK) is up 37% at $15.70. Adcare Health Systems Inc. (NYSEMKT: ADK) is up 36.7% at $5.88. Primus...
Published:
Last Updated:
Investors are on the hunt for fresh research ideas that will lead to higher income or more profits. Each and every morning we review many fresh research calls from Wall St. and from independent...
Published:
Last Updated:
thinkstockHere are today’s five biggest gaining stocks at closing: Genetic Technologies Ltd. (NASDAQ: GENE) is up 22.8% at $2.75. Theravance Inc. (NASDAQ: THRX) is up 19.4% at $28.36. Spar Group...
Published:
Last Updated:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated:
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s...
Published:
Last Updated:
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Published:
Last Updated:
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Published:
Last Updated:
Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average share price for...
Published:
US markets opened up slightly this morning and have maintained a slight positive tone for most of the day. Today marks the unofficial beginning of another earnings season, with Alcoa kicking things...
Published:
Last Updated:
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come from this sector due to the...
Published:
Last Updated:
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the ten-baggers that were seen in 2009. In 2009, companies like Jazz Pharmaceuticals, Inc....
Published:
Last Updated:
These are this Monday’s top ten analyst upgrades and downgrades seen from Wall Street research calls: Brookdale Senior Living Inc. (NYSE: BKD) Removed from Goldman Sachs Conviction Buy List. EOG...
Published:
Last Updated: